Device type17-Hydroxyprogesterone IVD, kit, enzyme immunoassay (EIA): A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of 17-hydroxyprogesterone in a clinical specimen, using an enzyme immunoassay (EIA) method. It is typically used to aid in the diagnosis of congenital adrenal hyperplasia (CAH).
FDA categoryRADIOIMMUNOASSAY, 17-HYDROXYPROGESTERONE
Device ID00816870021430
Catalog number5225-300A
AvailabilityPrescription
MRI safetyLabeling does not contain MRI Safety Information
Width7.75 Inch